Results 11 to 20 of about 54,056 (50)

Biochemical and histopathological changes in Wistar rats after consumption of boiled and un-boiled water from high and low disease prevalent areas for chronic kidney disease of unknown etiology (CKDu) in north Central Province (NCP) and its comparison with low disease prevalent Colombo, Sri Lanka

BMC Nephrology, 2020
Background Chronic Kidney Disease of unknown etiology (CKDu) is prevalent in North Central Province (NCP) of Sri Lanka. Consumption of un-boiled dug well water has been identified as one of the causative factors.
M. G. Thammitiyagodage, N. R. de Silva, C. Rathnayake, R. Karunakaran, Kumara WGSS, M. M. Gunatillka, N. Ekanayaka, B. P. Galhena, M. I. Thabrew   +8 more
doaj   +1 more source

Access to CKD Care in Rural Communities of India: a qualitative study exploring the barriers and potential facilitators

BMC Nephrology, 2020
Background Despite the high and rising burden of chronic kidney disease (CKD) in South Asia, factors that influence access to CKD care at the community level have not been studied previously, especially in the rural areas.
Tazeen Hasan Jafar, Chandrika Ramakrishnan, Oommen John, Abha Tewari, Benjamin Cobb, Helena Legido-Quigley, Yoon Sungwon, Vivekanand Jha   +7 more
doaj   +1 more source

Investigating associated factors with glomerular filtration rate: structural equation modeling

BMC Nephrology, 2020
Background Glomerular filtration rate (GFR) is a valid indicator of kidney function. Different factors can affect GFR. The purpose of this study is to assess the direct and indirect effects of GFR-related factors using structural equation modeling ...
Parastoo Jamshidi, Farid Najafi, Shayan Mostafaei, Ebrahem Shakiba, Yahya Pasdar, Behrooz Hamzeh, Mehdi Moradinazar   +6 more
doaj   +1 more source

Ambrisentan use in a HIV-1 infected patient with end-stage renal disease and pulmonary hypertension: minimal removal by hemodialysis - a case report

BMC Nephrology, 2020
Background Ambrisentan is a selective endothelin receptor antagonist used for the treatment of pulmonary arterial hypertension (PAH). Little is known about ambrisentan removal by hemodialysis in patients with end-stage renal disease (ESRD).
José Ramón Santos, Ana Merino, Walter E. Haefeli, Cristina Miranda, Marisol Prats, Ioana Bancu, Lucía Bailón, José Moltó   +7 more
doaj   +1 more source

Determinants of treatment in patients with stage IV renal cell carcinoma

BMC Urology, 2019
Background Advances in systemic targeted therapies afford treatment opportunities in patients with metastatic renal cell carcinoma (RCC). Elderly patients with metastatic RCC present a subpopulation for consideration owing to competing causes of ...
Christopher S. Hollenbeak, Eric W. Schaefer, Justin Doan, Jay D. Raman   +3 more
doaj   +1 more source

Correction to: Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990–2019: results from the global burden of disease study 2019

BMC Nephrology, 2022
Changrong Ke, Juanjuan Liang, Mi Liu, Shiwei Liu, Chunping Wang   +4 more
doaj   +1 more source

Erratum: Comparison of magnetic resonance defecography with pelvic floor ultrasound and vaginal inspection in the urogynecological diagnosis of pelvic floor dysfunction

Urology Annals, 2021
doaj   +1 more source

A rare cause of diarrhea in patients with focal segmental glomerulosclerosis

Nefrología, 2016
Osman Saglam, Selman Unverdi, Murat Duranay   +2 more
doaj   +1 more source

POS-618 INTERMITTENT PNEUMATIC COMPRESSION PROMOTES PRE-SURGERY CEPHALIC VEIN DILATION

Kidney International Reports, 2021
T. Singh, S. Mott, K. Beedon
doaj  

POS-772 50 YEARS FUNCTIONING RENAL GRAFT PERFORMED IN CHILDHOOD

Kidney International Reports, 2021
G. Sparta, K. Hadaya, P. Luc, E. Girardin, E. Leumann   +4 more
doaj